Position in KRYS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$27,123
+$22,312 QoQ
Shares Held
105
+200.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWIN PEAKS WEALTH ADVISORS, LLC holds $578,701 across 106 Biotechnology names. KRYS ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
280 | $125,031 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
159 | $122,849 | |
| 3 | GERN |
Geron Corp
|
27,444 | $40,891 | |
| 4 | KRYS |
Krystal Biotech, Inc.
This page
|
105 | $27,123 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
173 | $18,234 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
215 | $16,144 | |
| 7 | ARGX |
Argenx SE
|
21 | $15,335 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
73 | $14,574 |
All Filings in KRYS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,123 | 105 | Shares | Sole | 2026-05-08 | |
| 2025-06-30 | $4,811 | 35 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||